Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L. (March 2022) - Popat, Sanjay; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James; Han, Ji-Youn; Hochmair, Maximilian; Lee, Ki Hyeong; Delmonte, Angelo; Garcia Campelo, Maria; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; et al.